Findings from 2 early stage studies reported at a recent clinical meeting support the safety and tolerability of the GLP-1RA in persons with substance use disorders.
Erin O'Brien
Advertisement
Articles by Erin O'Brien
Advertisement
Latest Updated Articles
Semaglutide Explored for Treatment of Alcohol, Nicotine Use DisordersPublished: May 30th 2024 | Updated:
Advertisement
Advertisement
